Journal of Shanghai Jiao Tong University (Medical Science) >
Analysis of risk factors of adverse pregnancy outcomes in patients with chronic kidney disease
Received date: 2023-03-21
Accepted date: 2024-04-18
Online published: 2024-05-28
Objective ·To find out the risk factors leading to adverse pregnancy outcome by analyzing the correlation of clinical data and adverse pregnancy outcomes in patients with pregnancy complicated with chronic kidney disease. Methods ·The clinical data before 20 weeks of gestation of single pregnant patients discharged with a diagnosis of chronic kidney disease who conducted standardized prenatal examination and delivered in Renji Hospital, Shanghai Jiao Tong University School of Medicine from January 1, 2017 to December 31, 2021 were collected retrospectively. According to the pregnancy outcomes, patients were divided into adverse pregnancy outcome group (study group) and good pregnancy outcome group (control group). The clinical data, laboratory test results and pregnancy outcomes of the two groups of pregnant women were compared, and the risk factors leading to adverse pregnancy outcomes were analyzed. Results ·Maternal clinical data of 359 pregnant patients were collected, 6 cases of twin pregnancy were excluded, and the remaining 353 cases of pregnancy with chronic kidney disease were included in this study. Among them, 230 cases of pregnancy without related maternal and fetal complications were included in the good pregnancy outcome group (control group), and 123 cases of pregnancy with adverse maternal and fetal outcomes were included in the adverse pregnancy outcome group (study group). The adverse pregnancy outcome group (one pregnancy can have multiple adverse pregnancy outcomes) includes 69 cases of preeclampsia (including 43 cases of severe preeclampsia), 29 cases of acute kidney injury, 69 cases of premature delivery, 34 cases of infants smaller than gestational age, 46 cases of low birth weight infants, 41 cases of neonatal admission to NICU, and 7 cases of miscarriage after 20 weeks of gestation or neonatal death. There were no differences in age, body mass index, pregnancy times and birth times between the study group and control group. In patients with chronic kidney disease, those who had chronic hypertension (OR=3.385, 95% CI 1.115—10.726, P=0.031), serum creatinine over 60 μmol/L (OR=2.828, 95% CI 1.439—5.557, P=0.003), 24-hour urine protein≥0.3 g (OR=2.234, 95% CI 1.122—4.448, P=0.022), and lupus nephritis before 20 weeks of gestation (OR=4.917, 95% CI=1.967—12.290, P=0.001) were at significantly higher risk of adverse pregnancy outcomes. The area under the ROC curve was 0.759, the sensitivity was 52.8%, and the specificity was 84.2% for predicting adverse pregnancy outcomes in pregnant women with chronic kidney disease. Conclusion ·Chronic hypertension, 24-hour urine protein≥0.3 g, nephritis type of lupus nephritis and serum creatinine≥ 60 μmol/L before 20 weeks of gestation are independent risk factors for adverse pregnancy outcome in CKD patients. The combination of the above four indicators have a good predictive value for adverse pregnancy outcomes.
Key words: pregnancy; chronic kidney disease; adverse pregnancy outcome; risk factor
Yu LI , Yu ZHANG . Analysis of risk factors of adverse pregnancy outcomes in patients with chronic kidney disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(5) : 560 -566 . DOI: 10.3969/j.issn.1674-8115.2024.05.003
1 | 上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南(2022年版)[J]. 中华肾脏病杂志, 2022, 38(5): 453-464. |
1 | Expert Group on Kidney Clinical Quality Control Center in Shanghai. Guidelines for early screening, diagnosis, prevention and treatment of chronic kidney disease (2022 edition)[J]. Chinese Journal of Nephrology, 2022, 38(5): 453-464. |
2 | REYNOLDS M L, HERRERA C A. Chronic kidney disease and pregnancy[J]. Adv Chronic Kidney Dis, 2020, 27(6): 461-468. |
3 | HUI D N, HLADUNEWICH M A. Chronic kidney disease and pregnancy[J]. Obstet Gynecol, 2019, 133(6): 1182-1194. |
4 | PICCOLI G B, ZAKHAROVA E, ATTINI R, et al. Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases[J]. J Clin Med, 2018, 7(11): 415. |
5 | WILES K, CHAPPELL L, CLARK K, et al. Clinical practice guideline on pregnancy and renal disease[J]. BMC Nephrol, 2019, 20(1): 401. |
6 | 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4): 227-238. |
6 | Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)[J]. Chinese Journal of Obstetrics and Gynecology, 2020, 55(4): 227-238. |
7 | 国家慢性肾病临床医学研究中心, 中国医师协会肾脏内科医师分会, 中国急性肾损伤临床实践指南专家组. 中国急性肾损伤临床实践指南[J]. 中华医学杂志, 2023, 103(42): 3332-3366. |
7 | National Clinical Research Center for Kidney Diseases, Chinese Nephrologist Association, Expert Group on AKI Guidelines. Chinese clinical practice guideline for acute kidney injury[J]. Chinese Medical Journal, 2023, 103(42): 3332-3366. |
8 | 中华医学会妇产科学分会产科学组. 早产临床防治指南(2024版)[J]. 中华妇产科杂志, 2024, 59(4): 257-269. |
8 | Subgroup of Obstetrics, Society of Obstetrics and Gynecology, Chinese Medical Association. Clinical guidelines for the prevention and treatment of preterm birth (version 2024)[J]. Chinese Journal of Obstetrics and Gynecology, 2024, 59(4): 257-269. |
9 | NAKANO Y. Adult-onset diseases in low birth weight infants: association with adipose tissue maldevelopment[J]. J Atheroscler Thromb, 2020, 27(5): 397-405. |
10 | Fetal Growth Restriction: ACOG Practice Bulletin, Number 227[J]. Obstet Gynecol, 2021, 137(2): e16-e28. |
11 | PICCOLI G B, CABIDDU G, ATTINI R, et al. Risk of adverse pregnancy outcomes in women with CKD[J]. J Am Soc Nephrol, 2015, 26(8): 2011-2022. |
12 | IMBASCIATI E, GREGORINI G, CABIDDU G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes[J]. Am J Kidney Dis, 2007, 49(6): 753-762. |
13 | 南京总医院, 国家肾脏疾病临床医学研究中心. 慢性肾脏病患者妊娠管理指南[J]. 中华医学杂志, 2017, 97(46): 3604-3611. |
13 | National Clinical Research Center for Kidney Diseases, Nanjing General Hospital. Guidelines for the management of pregnancy in patients with chronic kidney disease[J]. Chinese Medical Journal, 2017, 97(46): 3604-3611. |
14 | HE Y D, LI Z, CHEN S, et al. Pregnancy in patients with stage 3-5 CKD: maternal and fetal outcomes[J]. Pregnancy Hypertens, 2022, 29: 86-91. |
15 | CHANG C Y, CHIEN Y J, KAO M C, et al. Pre-operative proteinuria, postoperative acute kidney injury and mortality: a systematic review and meta-analysis[J]. Eur J Anaesthesiol, 2021, 38(7): 702-714. |
16 | WILES K, BRAMHAM K, SEED P T, et al. Serum creatinine in pregnancy: a systematic review[J]. Kidney Int Rep, 2019, 4(3): 408-419. |
17 | HAREL Z, MCARTHUR E, HLADUNEWICH M, et al. Serum creatinine levels before, during, and after pregnancy[J]. JAMA, 2019, 321(2): 205-207. |
18 | KUPER S G, TITA A T, YOUNGSTROM M L, et al. Baseline renal function tests and adverse outcomes in pregnant patients with chronic hypertension[J]. Obstet Gynecol, 2016, 128(1): 93-103. |
19 | DVO?áK J, KOUCKY M, JAN?OVá E, et al. Chronic kidney disease and pregnancy outcomes[J]. Sci Rep, 2021, 11(1): 21299. |
20 | PICCOLI G B, ATTINI R, CABIDDU G, et al. Maternal-foetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy?[J]. J Autoimmun, 2017, 79: 91-98. |
/
〈 |
|
〉 |